Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$30.46 - $46.04 $1.27 Million - $1.92 Million
-41,731 Reduced 78.0%
11,767 $358,000
Q2 2023

Aug 14, 2023

BUY
$31.57 - $37.73 $884,275 - $1.06 Million
28,010 Added 109.89%
53,498 $2 Million
Q1 2023

May 12, 2023

SELL
$29.72 - $41.45 $1.24 Million - $1.72 Million
-41,587 Reduced 62.0%
25,488 $814,000
Q4 2022

Feb 13, 2023

BUY
$30.23 - $38.71 $108,011 - $138,310
3,573 Added 5.63%
67,075 $2.39 Million
Q3 2022

Nov 14, 2022

BUY
$22.51 - $38.27 $94,879 - $161,308
4,215 Added 7.11%
63,502 $1.85 Million
Q2 2022

Aug 17, 2022

SELL
$20.97 - $37.47 $909,447 - $1.63 Million
-43,369 Reduced 42.25%
59,287 $1.33 Million
Q1 2022

May 16, 2022

BUY
$34.38 - $65.77 $2.23 Million - $4.27 Million
64,882 Added 171.76%
102,656 $3.79 Million
Q4 2021

Feb 11, 2022

BUY
$63.78 - $97.86 $785,897 - $1.21 Million
12,322 Added 48.41%
37,774 $2.67 Million
Q3 2021

Nov 12, 2021

SELL
$45.58 - $88.24 $1.27 Million - $2.45 Million
-27,784 Reduced 52.19%
25,452 $4.06 Million
Q2 2021

Aug 16, 2021

SELL
$34.4 - $48.34 $40,110 - $56,364
-1,166 Reduced 2.14%
53,236 $5.04 Million
Q1 2021

May 12, 2021

BUY
$23.17 - $38.3 $6,835 - $11,298
295 Added 0.55%
54,402 $3.94 Million
Q4 2020

Feb 12, 2021

BUY
$18.28 - $23.85 $228,372 - $297,958
12,493 Added 30.02%
54,107 $2.57 Million
Q3 2020

Nov 12, 2020

BUY
$12.91 - $18.51 $537,236 - $770,275
41,614 New
41,614 $1.51 Million
Q2 2020

Aug 13, 2020

SELL
$9.68 - $17.5 $281,920 - $509,670
-29,124 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$7.43 - $24.88 $130,745 - $437,813
17,597 Added 152.66%
29,124 $626,000
Q4 2019

Feb 11, 2020

BUY
$11.01 - $27.92 $126,912 - $321,833
11,527 New
11,527 $452,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.45B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.